CREB1 and Alzheimer disease: Previous studies showed that PKA provided important neuroprotective effects and reduced neuronal apoptosis through the p38 MAPK/CREB or CREB/BDNF signaling pathway in various CNS conditions, including ischemic brain injury, Parkinson's disease, and AD [63–66].